RxDoctor Payments DataLook up a doctor →

Richard Hall, MD

Medical Oncology · Charlottesville, VANPI 1649474040

Payments from drug & device makers

$1,741,918in general payments, 2019–2025

Across 251 payments — averaging $6939.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$586K
  • Amgen$485K
  • Regeneron$447K
  • Merck$132K
  • AstraZeneca$37K
  • Mirati Therapeutics, Inc.$19K
  • plus $36K from 10 others

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,741,918 in reported general payments places this provider in the 85th percentile of 95 medical oncology providers in Virginia.

See all medical oncology providers in Virginia

Medicare billing

Part B allowed, 2024
$71,276
Medicare patients
164
Services billed
880

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Charlottesville

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →